Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis
This retrospective study suggests that sorafenib maintenance seem to be effective even in patients pre-treated with midostaurin.
Authors
- Valeria Calafiore (ORCID: https://orcid.org/0000-0002-7647-1621)
- Domenica Matranga (ORCID: https://orcid.org/0000-0002-2466-937X)
- Cristina Rotolo (ORCID: https://orcid.org/0000-0001-7737-6290)
- Luca Castagna (ORCID: https://orcid.org/0000-0002-6239-7387)
- Cecilia Agueli
- Valentina Randazzo
- Alessandra Santoro (ORCID: https://orcid.org/0009-0003-3275-4405)
- Giuseppe Sapienza (ORCID: https://orcid.org/0000-0002-0149-0764)
- Caterina Patti (ORCID: https://orcid.org/0009-0006-4316-9254)
- Stefania Tringali
- Roberto Bono
- Antonino Mulè (ORCID: https://orcid.org/0009-0006-4162-2051)
- Marta Castronovo
Institutions
- Ospedale Vincenzo Cervello (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3389/fonc.2024.1441254
- Citations
- 4
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.82